Companies that own Xencor Inc.
Fidelity Management & Research Co.
8,189,953
14.67%
135,559
0.04%
06/30/2018
PRIMECAP Management Co.
7,566,943
13.56%
91,300
0.21%
06/30/2018
Ronin Capital LLC
7,018,848
12.57%
-111,700
93.82%
07/17/2018
T. Rowe Price Associates, Inc.
6,285,462
11.26%
310,531
0.04%
06/30/2018
BlackRock Fund Advisors
3,578,217
6.41%
790,842
0.01%
06/30/2018
Redmile Group LLC
3,147,043
5.64%
-57,300
4.07%
06/30/2018
The Vanguard Group, Inc.
3,061,108
5.48%
1,013,042
0%
06/30/2018
SSgA Funds Management, Inc.
1,439,074
2.58%
378,065
0.01%
06/30/2018
Perceptive Advisors LLC
1,068,095
1.91%
-250,000
1.02%
06/30/2018
Baker Bros. Advisors LP
872,072
1.56%
0
0.24%
06/30/2018
| Address |
111 West Lemon Avenue
Monrovia California 91016
United States
|
|
Employees
|
- |
| Website |
http://www.xencor.com |
| Updated |
07/08/2019 |
| Xencor, Inc. engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. |
